Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1423-0127
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation ; volume:22 ; number:1 ; day:1 ; month:8 ; year:2015 ; pages:1-11 ; date:12.2015
Journal of biomedical science ; 22, Heft 1 (1.8.2015), 1-11, 12.2015
- Urheber
-
Liu, Ya-Wei
Chiu, Yung-Tsung
Fu, Shu-Ling
Huang, Yi-Tsau
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12929-015-0168-5
- URN
-
urn:nbn:de:101:1-2021082106502385223537
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Ya-Wei
- Chiu, Yung-Tsung
- Fu, Shu-Ling
- Huang, Yi-Tsau
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis
DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling
Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability
Hepatic stellate cells: central modulators of hepatic carcinogenesis
Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy
Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells
Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells
miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis
DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling
Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability
Hepatic stellate cells: central modulators of hepatic carcinogenesis
Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy
Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells
Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells
miR-324-3p Suppresses Hepatic Stellate Cell Activation and Hepatic Fibrosis Via Regulating SMAD4 Signaling Pathway
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Bone morphogenetic protein 13 in hepatic stellate cells and hepatic fibrosis
DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling
Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability
Hepatic stellate cells: central modulators of hepatic carcinogenesis
Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy
Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells
Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells